Anti-Alpha Synuclein Oligomer Antibody [9D2]

(No reviews yet) Write a Review
SKU:
STMA00226
Antibody Type:
Monoclonal
Applications:
WB
Applications:
IHC
Applications:
ELISA
Reactivity:
Human
Host Species:
Mouse
Isotype:
IgG1 Kappa
  • Dot blot analysis comparing binding affinity of STMA00226 on 10, 50, and 100 ng of Human Recombinant Alpha Synuclein Monomers, Pre-Formed Fibrils, and Dopamine-Stabilized Oligomers. Block: 5% skim milk for 1 hour at RT. Primary Antibody: Mouse Anti-Human Alpha Synuclein Oligomer [9D2] (STMA00226) at 1:1000 for 2 hours at RT. Secondary Antibody: Goat anti-mouse IgG:HRP (Rockland Cat # 710-1331) at 1:4000 for 1 hour at RT.
  • Sandwich ELISA analysis comparing detection of Human Recombinant Alpha Synuclein Monomers. The range tested for each construct was 0 to 10 ng/mL. Block: 1% BSA + 5% Sucrose in PBS pH 7.4 for 1 hour at RT. Detection antibody: HRP-conjugated and incubated for 1 hour at RT. Colour Development: TMB Substrate.
  • Immunohistochemistry (IHC) analysis with STMA00226. Tissues: healthy and Parkinson’s Diseased human brains. Epitope Retrieval: EDTA-based buffer pH 9.0 (Leica Biosystems Cat # AR9640), boiled for 20 min. Blocking: 3% peroxide for 10 minutes at RT. Primary: Mouse Anti-Human Alpha Synuclein Oligomer Monoclonal Antibody, Clone 9D2 (STMA00226) at 1:200 for 30 minutes at RT. Secondary: Post-Primary for 10 min at RT.
Frequently bought together:

Description

Alpha Synuclein Oligomer Antibody [9D2]

Alpha Synuclein Oligomer Antibody [9D2] is a mouse monoclonal antibody directed against Alpha Synuclein Oligomer, offered by Assay Genie for research applications. Reported applications include WB, IHC and ELISA. Reported reactivity: Human. Supplied as IgG1 Kappa, purified by Protein G.

Alpha synuclein oligomers represent a soluble, neurotoxic form of the presynaptic protein and are increasingly recognized as early drivers of pathology in neurodegenerative disease. These oligomeric species disrupt synaptic vesicle trafficking and neurotransmission, impairing presynaptic function well before the formation of mature fibrillar aggregates. Localized effects extend to mitochondria, where oligomers induce oxidative stress, lysosomal dysfunction, and endoplasmic reticulum stress, contributing to neuronal vulnerability in Parkinson’s disease (PD) and related synucleinopathies. Their capacity to propagate in a prion‑like manner and initiate early synaptic and inflammatory disturbances underscores their importance in disease progression and positions them as high‑value targets for biomarker development and therapeutic intervention. This Alpha Synuclein Oligomer Antibody, clone 9D2, has demonstrated higher affinity to oligomers than to PFFs or monomers. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose